naftopidil and Ovarian Neoplasms

naftopidil has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abeilard, E; Babin, G; Brotin, E; Florent, R; Lambert, B; Louis, MH; N'Diaye, M; Poulain, L; Weiswald, LB	1

Other Studies

1 other study(ies) available for naftopidil and Ovarian Neoplasms

Article	Year
Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib. Cell death & disease, 2020, 05-18, Volume: 11, Issue:5 Topics: Apoptosis Regulatory Proteins; bcl-X Protein; Biphenyl Compounds; Female; Humans; Mitogen-Activated Protein Kinase Kinases; Naphthalenes; Nitrophenols; Ovarian Neoplasms; Piperazines; Pyridones; Pyrimidinones; Sulfonamides; Up-Regulation	2020

Article

Year

Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib.

Cell death & disease, 2020, 05-18, Volume: 11, Issue:5

Topics: Apoptosis Regulatory Proteins; bcl-X Protein; Biphenyl Compounds; Female; Humans; Mitogen-Activated Protein Kinase Kinases; Naphthalenes; Nitrophenols; Ovarian Neoplasms; Piperazines; Pyridones; Pyrimidinones; Sulfonamides; Up-Regulation

2020